238 related articles for article (PubMed ID: 29328503)
1. Challenges and Opportunities With Oncology Drug Development in China.
Bajaj G; Gupta M; Wang HH; Barrett JS; Tan M; Rupalla K; Bertz R; Sheng J
Clin Pharmacol Ther; 2019 Feb; 105(2):363-375. PubMed ID: 29328503
[TBL] [Abstract][Full Text] [Related]
2. Oncology Therapy Drugs in China, Japan, and the United States: Pharmacokinetic Characteristics, Dose Regimens, and Development Strategies.
Zhou L; Higashimori M; Shen K; Zhang Z; Sheng J; Xu H; Horiuchi M; Ichikawa K; Al-Huniti N; Zhou D
Clin Pharmacol Ther; 2019 Jun; 105(6):1303-1320. PubMed ID: 30802932
[No Abstract] [Full Text] [Related]
3. Changes in clinical trials of cancer drugs in mainland China over the decade 2009-18: a systematic review.
Li N; Huang HY; Wu DW; Yang ZM; Wang J; Wang JS; Wang SH; Fang H; Yu Y; Bai Y; Yan Z; Cao Y; Jiang M; Liu YF; Li KY; Xu BH; Sun Y; He J
Lancet Oncol; 2019 Nov; 20(11):e619-e626. PubMed ID: 31674320
[TBL] [Abstract][Full Text] [Related]
4. New drug approvals in oncology.
Kurzrock R; Kantarjian HM; Kesselheim AS; Sigal EV
Nat Rev Clin Oncol; 2020 Mar; 17(3):140-146. PubMed ID: 32020042
[TBL] [Abstract][Full Text] [Related]
5. Cancer drug development in China: recent advances and future challenges.
Wu YL; Zhang H; Yang Y
Drug Discov Today; 2015 Jun; 20(6):766-71. PubMed ID: 25463037
[TBL] [Abstract][Full Text] [Related]
6. Challenges and opportunities in oncology drug development and clinical research in China.
Wang F; Ruan DY; Xu RH
Cell; 2024 Mar; 187(7):1578-1583. PubMed ID: 38552607
[TBL] [Abstract][Full Text] [Related]
7. The RACE to accelerate drug development for children with cancer.
Pearson ADJ; Karres D; Reaman G; DuBois SG; Knox L; Scobie N; Vassal G
Lancet Child Adolesc Health; 2020 Oct; 4(10):714-716. PubMed ID: 32822672
[No Abstract] [Full Text] [Related]
8. Oncology approvals in 2020: a year of firsts in the midst of a pandemic.
Amiri-Kordestani L; Pazdur R
Nat Rev Clin Oncol; 2021 Mar; 18(3):129-130. PubMed ID: 33514911
[TBL] [Abstract][Full Text] [Related]
9. Rapid advances in research on and development of anticancer drugs in China.
Yao X; Du N; Hu S; Wang L; Gao J
Biosci Trends; 2019 Nov; 13(5):461-463. PubMed ID: 31511442
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
Printz C
Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
[No Abstract] [Full Text] [Related]
11. [Future cancer care challenges the health care].
Olofsson S
Lakartidningen; 2010 Apr 21-27; 107(16):1065. PubMed ID: 20476702
[No Abstract] [Full Text] [Related]
12. American Society of Clinical Oncology Position Statement on Addressing the Affordability of Cancer Drugs.
American Society of Clinical Oncology
J Oncol Pract; 2018 Mar; 14(3):187-192. PubMed ID: 29091534
[No Abstract] [Full Text] [Related]
13. Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology.
Ji Y; Jin JY; Hyman DM; Kim G; Suri A
Clin Transl Sci; 2018 Jul; 11(4):345-351. PubMed ID: 29392871
[No Abstract] [Full Text] [Related]
14. Cross-boundary cancer studies at the University of Tokyo: Oncology in Asian countries: clinical development challenges and opportunities.
Rigaudy P
Jpn J Clin Oncol; 2014 Feb; 44 Suppl 1():i54-59. PubMed ID: 24516214
[No Abstract] [Full Text] [Related]
15. Emerging Opportunities and Challenges of Biosimilars in Oncology Practice.
Lyman GH
J Oncol Pract; 2017 Sep; 13(9_suppl):7s-9s. PubMed ID: 28898591
[No Abstract] [Full Text] [Related]
16. ASCO 2011: broadening the horizons of cancer research.
Crane K
J Natl Cancer Inst; 2011 Jul; 103(13):999-1001. PubMed ID: 21693729
[No Abstract] [Full Text] [Related]
17. [Introduction].
Koch M; Monneret C
Ann Pharm Fr; 2005 Jan; 63(1):4-6. PubMed ID: 15803093
[No Abstract] [Full Text] [Related]
18. Advances in drug development: off-label drug utilization in oncology.
de Souza JA
Clin Adv Hematol Oncol; 2011 Jun; 9(6):473-5. PubMed ID: 21841748
[No Abstract] [Full Text] [Related]
19. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
20. [From biology to innovating treatments for tumors: a long struggle].
Thiery JP
Ann Pharm Fr; 2005 Jan; 63(1):7-9. PubMed ID: 15803094
[No Abstract] [Full Text] [Related]
[Next] [New Search]
